EFFECTS OF DIRECT ORAL ANTICOAGULANTS ON THROMBOELASTOGRAPHIC PARAMETERS AND FIBRIN CLOT PROPERTIES IN PATIENTS WITH VENOUS THROMBOEMBOLISM.

KOPYTEK, M.; ZABCZYK, M.; NATORSKA, J.; MALINOWSKI, K. P.; UNDAS, A.

Data concerning the impact of direct oral anticoagulants (DOACs) on the thromboelastography (TEG) indices in venous thromboembolism (VTE) patients are limited. The goal of this study was to compare the impact of DOACs on clot properties measured in whole blood using TEG kaolin test and in plasma obtained from real-life VTE patients. We assessed 53 patients, including 20 on rivaroxaban, 20 on apixaban, and 13 on dabigatran. Using the TEG® 5000, coagulation status was evaluated in whole blood samples, while plasma fibrin clot permeability (Ks) and its susceptibility to lysis (CLT) were assessed in citrated plasma. Plasma concentrations of rivaroxaban (99 [48 - 311] ng/ml) and apixaban (85 [40 - 105] ng/ml) were positively associated with Ks and inversely with CLT, while dabigatran concentrations (71 [39 - 98] ng/ml) correlated positively with Ks. Moreover, Ks was associated with clot formation times (R and K), time to maximum clot strength (TMA), coagulation index (CI) reflecting the overall coagulation status, and whole blood clot lysis time (TEG-CLT). Blood clot lysis index (CL30) was associated with plasma CLT in all patients on DOACs, while TMA correlated with CLT only in patients on apixaban. Higher DOAC concentrations were associated with longer retardation of whole blood clot formation and longer time needed to reach maximum level of its strength as well as with more permeable clots. We concluded that plasma fibrin clot properties correlate with corresponding TEG indices suggesting that TEG might be helpful in providing prognostic information about DOAC influence in VTE patients.

ANTICOAGULANTS; FIBRIN; THROMBOEMBOLISM; HEMATOPOIESIS; BLOOD coagulation

Journal of Physiology & Pharmacology, 2020, Vol 71, Issue 1, p1

0867-5910

Academic Journal

10.26402/jpp.2020.1.03